_version_ 1784717929482289152
author Geinitz, H.
Silberberger, E.
Spiegl, K.
Feichtinger, J.
Track, C.
Weis, E.
Venhoda, C.
Huppert, R.
Bräutigam, E.
Aschacher, B.
Kocik, L.
Karasek, N.
Fischerlehner, B.
Gruber, G.
Bihary, D.V.
Erdei, M.
Kirchner, K.
Zauner-Barbor, G.
Ecker, M.
Spindelbalker-Renner, B.
Adler, R.
Thöne, P.
Dieplinger, B.
author_facet Geinitz, H.
Silberberger, E.
Spiegl, K.
Feichtinger, J.
Track, C.
Weis, E.
Venhoda, C.
Huppert, R.
Bräutigam, E.
Aschacher, B.
Kocik, L.
Karasek, N.
Fischerlehner, B.
Gruber, G.
Bihary, D.V.
Erdei, M.
Kirchner, K.
Zauner-Barbor, G.
Ecker, M.
Spindelbalker-Renner, B.
Adler, R.
Thöne, P.
Dieplinger, B.
author_sort Geinitz, H.
collection PubMed
description
format Online
Article
Text
id pubmed-9153885
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ireland Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91538852022-05-31 PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy Geinitz, H. Silberberger, E. Spiegl, K. Feichtinger, J. Track, C. Weis, E. Venhoda, C. Huppert, R. Bräutigam, E. Aschacher, B. Kocik, L. Karasek, N. Fischerlehner, B. Gruber, G. Bihary, D.V. Erdei, M. Kirchner, K. Zauner-Barbor, G. Ecker, M. Spindelbalker-Renner, B. Adler, R. Thöne, P. Dieplinger, B. Radiother Oncol Poster (digital): Mixed sites/palliation Elsevier Ireland Ltd. 2022-05 2022-05-31 /pmc/articles/PMC9153885/ http://dx.doi.org/10.1016/S0167-8140(22)03437-5 Text en Copyright © 2022 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster (digital): Mixed sites/palliation
Geinitz, H.
Silberberger, E.
Spiegl, K.
Feichtinger, J.
Track, C.
Weis, E.
Venhoda, C.
Huppert, R.
Bräutigam, E.
Aschacher, B.
Kocik, L.
Karasek, N.
Fischerlehner, B.
Gruber, G.
Bihary, D.V.
Erdei, M.
Kirchner, K.
Zauner-Barbor, G.
Ecker, M.
Spindelbalker-Renner, B.
Adler, R.
Thöne, P.
Dieplinger, B.
PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
title PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
title_full PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
title_fullStr PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
title_full_unstemmed PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
title_short PO-1473 Effectiveness and tolerability of SARS-CoV-2 vaccination in patients undergoing radiotherapy
title_sort po-1473 effectiveness and tolerability of sars-cov-2 vaccination in patients undergoing radiotherapy
topic Poster (digital): Mixed sites/palliation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153885/
http://dx.doi.org/10.1016/S0167-8140(22)03437-5
work_keys_str_mv AT geinitzh po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT silberbergere po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT spieglk po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT feichtingerj po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT trackc po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT weise po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT venhodac po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT huppertr po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT brautigame po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT aschacherb po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT kocikl po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT karasekn po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT fischerlehnerb po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT gruberg po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT biharydv po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT erdeim po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT kirchnerk po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT zaunerbarborg po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT eckerm po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT spindelbalkerrennerb po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT adlerr po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT thonep po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy
AT dieplingerb po1473effectivenessandtolerabilityofsarscov2vaccinationinpatientsundergoingradiotherapy